肺炎E病毒快速檢測套組市場報告：趨勢、預測和競爭分析（至2031年）

由於診斷中心、醫院和家庭使用市場的需求，全球E型肺炎病毒快速檢測套組市場預計將成為一個前景看好的市場。該市場預計在2025年至2031年間將以4.6%的年複合成長率成長。主要成長要素包括E型肝炎的日益普及、對快速診斷方法的需求不斷成長以及人們對感染疾病的認知不斷提高。

• 根據 Lucintel 的預測，膠體金法在預測期內有望實現最高的成長率。
• 根據應用來看，診斷中心預計將迎來最高的成長率。
• 從區域來看，預計亞太地區在預測期內將達到最高的成長率。

快速E型肺炎病毒檢測套組市場的新趨勢

E型肺炎病毒快速檢測套組市場正經歷持續創新期，一系列關鍵趨勢湧現，並改變產品開發和臨床應用。這些變化直接源於醫療保健相關人員不斷變化的需求，即更加重視早期檢測、快速診療以及在資源匱乏環境下的可近性。這些趨勢預示著市場正朝著更先進、更全面的解決方案發展，以促進HEV感染的快速且準確診斷。

• 即時檢測技術的發展：一個關鍵趨勢是開發可在醫療點使用的快速檢測套組。這些檢測操作簡便，所需訓練和基礎設施極少。這顯著提高了診斷的可及性，尤其是在檢查室基礎設施匱乏的偏遠和資源匱乏地區。即時檢測能夠實現早期及時診斷，這對於控制疫情和即時醫療干預非常重要。
• 多重檢測簡介：目前研發的多重檢測技術能夠同時檢測E型肝炎病毒（HEV）和其他病毒性肝炎標記（例如A型、B型和C型肝炎）。這使得單次檢測即可進行鑑別診斷，提供了一種更有效率、更便捷的診斷方法，並能節省時間和成本。這對於臨床上出現特異性急性肝炎症狀的患者尤其重要。
• 提高靈敏度和特異性：快速檢測套組靈敏度和特異性的持續提高是目前最重要的趨勢之一。各公司正應用新型重組抗原和最新的免疫檢測技術，以降低假陽性和假陰性的發生率。這提高了診斷準確性，增強了醫護人員的信心，並有助於做出更準確的診斷。這一趨勢在臨床實踐和公共衛生領域都發揮著非常重要的作用。
• 數位健康解決方案的整合：一項關鍵發展是將數位健康解決方案與快速檢測套組整合，例如，利用行動應用程式解讀檢測結果，並將資料安全地傳輸到中央資料庫，即時追蹤流行病學模式。這將徹底改變公共衛生監測方式，使公共衛生部門更有效地追蹤疫情爆發並部署資源。這一趨勢利用科技來改善特定患者照護和整體公共衛生狀況。
• 快速E型肝炎病毒（HEV）快速檢測套組的應用範圍正穩定地擴展至獸醫學和血液篩檢領域，超越了人類臨床診斷的範疇。這些應用包括獸醫學領域，特別是豬的獸醫學檢測，以及捐血的常規篩檢。這顯著拓展了市場，使其涵蓋了更多新領域。推動這一現象的因素是人們日益認知到HEV是一種通用感染疾病，以及確保血液製品安全性的迫切需求。

這些新興趨勢共同重塑E型肺炎病毒快速檢測套組市場。科技的進步，包括可及性和準確性的提高，滿足了醫護人員和病患的基本需求。向新應用和照護現場解決方案的多元化發展，正引領市場邁入新時代，鞏固其作為全球公共衛生新格局中關鍵工具的地位。

E型肺炎病毒快速檢測套組市場近期趨勢

過去幾年，E型肺炎病毒快速檢測套組市場經歷了許多重大發展，從根本上重新定義了其在現代醫療保健中的應用範圍和價值。這些進步並非只是漸進式的改進，而是代表著一種目的是提升檢測性能、增強臨床療效並解決緊迫的公共衛生和安全問題的策略性方法。這些進步主要得益於技術的進步以及對能夠改善患者預後和最佳化醫療實踐的產品的需求。

• 全自動免疫檢測的出現：一項關鍵進展是用於檢測E型肝炎病毒（HEV）抗體和抗原的全自動免疫檢測的出現。這項由大型診斷公司主導的創新標誌著檢測方式從人工快速檢測向自動化檢測的重大轉變，顯著提高了檢測效率並減少了人為誤差。這些平台能夠實現高通量篩檢，這對於大型診斷檢查室和血庫，尤其是在已開發國家，非常重要。
• E型肝炎病毒（HEV）抗原檢測試劑盒的研發：近期一項重要進展是HEV抗原快速檢測套組的商業化。這意義重大，因為與單獨檢測抗體相比，抗原檢測有助於更早診斷急性感染。這使得診斷更加及時準確，使臨床醫生能夠更早啟動治療和患者管理。這項進展滿足了疾病急性期快速診斷的重要臨床需求。
• 關注E型肝炎病毒（HEV）基因型鑑別：人們越來越關注開發能夠區分主要HEV基因型（尤其是1型和3型基因型）的快速檢測套組，這兩種基因型在世界各地廣泛流行。這不僅能提供更詳細的HEV流行病學訊息，還能實現更有針對性的臨床管理。這項創新對於監測工作非常重要，並可指南有針對性的公共衛生干預措施，以遏制特定HEV變異株的傳播。
• 重組抗原的應用：製造商擴大採用重組抗原來提高快速檢測套組的性能。基因工程抗原比源自天然病毒的抗原具有更高的純度和均一性。這提高了試劑盒的敏感度和特異性，獲得更可靠的結果，並減少了確認性檢測的頻率。這項優勢有助於提高快速診斷平台的可靠性。
• 擴展的血清學和分子診斷組合：一項重要的進展是擴展了診斷組合，使其涵蓋血清學（抗體）和分子（RNA）檢測。這提供了一種全面的診斷方法，使臨床醫生能夠區分急性感染和慢性感染並評估病毒量。這提高了診斷準確性，對於治療複雜感染疾病（例如E型肝炎病毒感染）非常重要，尤其是在免疫力缺乏的患者中。

這五項重大進展均對E型肺炎病毒快速檢測套組市場產生了顯著影響。對高性能自動化、先進抗原檢測和更高特異性的關注，使檢測更加高效和通用。這些進展不僅改善了產品特性，還有助於提高患者照護水準和公共衛生監測能力，實現更有效地診斷和治療E型肝炎病毒感染。

目錄

第1章 執行摘要

第2章 市場概覽

• 背景和分類
• 供應鏈

第3章 市場趨勢與預測分析

• 產業促進因素與挑戰
• PESTLE分析
• 專利分析
• 法規環境

第4章 全球E型肺炎病毒快速檢測套組市場（依類型）

• 吸引力分析：依類型
• 酵素免疫分析法
• 探針法
• 膠體金法
• 其他

第5章 全球E型肺炎病毒快速檢測套組市場（依應用）

• 吸引力分析：依應用
• 診斷中心
• 醫院
• 家用

第6章 區域分析

第7章 北美E型肺炎病毒快速檢測套組市場

• 北美E型肺炎病毒快速檢測套組市場（依類型）
• 北美E型肺炎病毒快速檢測套組市場（依應用）
• 美國E型肺炎病毒快速檢測套組市場
• 墨西哥E型肺炎病毒快速檢測套組市場
• 加拿大E型肺炎病毒快速檢測套組市場

第8章 歐洲E型肺炎病毒快速檢測套組市場

• 歐洲E型肺炎病毒快速檢測套組市場（依類型）
• 歐洲E型肺炎病毒快速檢測套組市場（依應用）
• 德國E型肺炎病毒快速檢測套組市場
• 法國E型肺炎病毒快速檢測套組市場
• 西班牙E型肺炎病毒快速檢測套組市場
• 義大利E型肺炎病毒快速檢測套組市場
• 英國E型肺炎病毒快速檢測套組市場

第9章 亞太地區E型肺炎病毒快速檢測套組市場

• 亞太地區E型肺炎病毒快速檢測套組市場（依類型）
• 亞太地區E型肺炎病毒快速檢測套組市場（依應用）
• 日本E型肺炎病毒快速檢測套組市場
• 印度E型肺炎病毒快速檢測套組市場
• 中國E型肺炎病毒快速檢測套組市場
• 韓國E型肺炎病毒快速檢測套組市場
• 印尼E型肺炎病毒快速檢測套組市場

第10章 世界其他地區（ROW）E型肺炎病毒快速檢測套組市場

• ROWE型肺炎病毒快速檢測套組市場（依類型）
• ROWE型肺炎病毒快速檢測套組市場（依應用）
• 中東E型肺炎病毒快速檢測套組市場
• 南美洲E型肺炎病毒快速檢測套組市場
• 非洲E型肺炎病毒快速檢測套組市場

第11章 競爭分析

• 產品系列分析
• 運作整合
• 波特五力分析
• 市場佔有率分析

第12章 機會與策略分析

• 價值鏈分析
• 成長機會分析
• 全球E型肺炎病毒快速檢測套組市場新興趨勢
• 戰略分析

第13章 價值鏈中主要企業的概況

• 競爭分析
• CTK Biotech
• Abbexa
• Fortress Diagnostics
• MP Diagnostics
• Healgen
• Bio-Medical Laboratory Supplies
• Creative Diagnostics
• Athenese-Dx
• Biozek Medical
• Diagnostic Automation/Cortez Diagnostics

第14章 附錄

The future of the global hepatitis E virus rapid test kit market looks promising with opportunities in the diagnostic center, hospital, and family expenses markets. The global hepatitis E virus rapid test kit market is expected to grow with a CAGR of 4.6% from 2025 to 2031. The major drivers for this market are the increasing prevalence of hepatitis E, the rising demand for rapid diagnostics, and the growing awareness of infectious diseases.

• Lucintel forecasts that, within the type category, colloidal gold method is expected to witness the highest growth over the forecast period.
• Within the application category, diagnostic center is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Hepatitis E Virus Rapid Test Kit Market

The hepatitis E virus rapid test kit market is itself in a phase of ongoing innovation, with a number of leading trends emerging that are transforming its product development and clinical use. These changes are the direct result of the changing requirements of the healthcare fraternity, with an increased emphasis on the early detection, procedural expediency, and accessibility in resource-constrained environments. The trends indicate a shift towards more advanced and holistic solutions to facilitate fast and precise diagnosis of HEV infections.

• Point-of-Care Test Development: One major trend has been towards developing quick test kits for use at the point of care. Such tests are easy to use and need minimal training and infrastructure. The effect is a very high increase in accessibility to diagnosis, especially in remote or resource-poor areas where laboratory infrastructure is not available. POC tests allow for early and on-time diagnosis, which is essential in controlling outbreaks and allowing immediate medical intervention.
• Introduction of Multiplex Assays: Development of multiplex assays capable of detecting HEV in combination with other viral hepatitis markers, for example, Hepatitis A, B, or C, is on the increase. The effect is a superior and more efficient diagnostic test that reduces time and cost by allowing for differential diagnosis in one test. This is especially important in the clinical environment where patients may have non-specific acute hepatitis symptoms.
• Increased Sensitivity and Specificity: One of the most important trends is the ongoing improvement in the sensitivity and specificity of quick test kits. Companies are applying new recombinant antigens and newer immunoassay technologies to reduce the possibility of false positive and false negative results. The effect is an increased level of diagnostic accuracy, which enhances the confidence of healthcare professionals and delivers a more precise diagnosis. This trend plays a vital role in both clinical and public health applications.
• Integration of Digital Health Solutions: One major development is the integration of digital health solutions with rapid test kits. Examples include mobile apps that can interpret test results and securely send data to a central database for real-time tracking of epidemiological patterns. The effect is a new revolution in public health surveillance, allowing public health authorities to track outbreaks and deploy resources better. This trend utilizes technology to enhance both specific patient care and general public health outcomes.
• Expansion into Veterinary Medicine and Blood Screening: There is a definitive and increasing tendency to use HEV rapid test kits in new uses outside of human clinical diagnostics. These include a concentration on veterinary medicine, especially for swine, and routine screening of blood donations. The effect is the extensive growth of the market into new areas. This phenomenon is fueled by increasing awareness of HEV as a zoonotic infection and a requirement for ensuring the safety of blood products.

Combined, these new trends are redefining the hepatitis E virus rapid test kit market. The move toward greater accessibility, encompassing technology, and increased accuracy is meeting the fundamental requirements of both practitioners and patients. The diversification into new uses and point-of-care solutions are bringing the market into the new era and cementing its position as a key tool in the new world of global public health.

Recent Developments in the Hepatitis E Virus Rapid Test Kit Market

The hepatitis E virus rapid test kit market has witnessed a number of important developments over the past few years that are essentially redefining its application and worth in contemporary medicine. These are not mere incremental refinements but are indicative of a strategic approach towards improving test performance, increasing clinical efficacy, and responding to compelling public health and safety issues. These advances are fueled mainly by advances in technology and the need for products that enhance patient outcomes and optimize medical practice.

• Release of Fully Automated Immunoassays: A principal development is the release of fully automated immunoassay analyzers to detect HEV antibody and antigen. This innovation, spearheaded by the leading diagnostic firms, represents a principal move away from manual quick tests. The effect is a tremendous enhancement of testing efficiency and less human error. These platforms allow high-throughput screening, which is a critical requirement for large diagnostic labs and blood banks, especially in the developed world.
• HEV Antigen Detection Kit Development: A significant recent improvement has been the commercial release of rapid test kits for detecting the HEV antigen. This is significant because antigen detection can lead to earlier diagnosis of acute infection compared to antibody detection in isolation. The consequence is an earlier and more accurate diagnosis, enabling clinicians to initiate treatment or patient management earlier. This development addresses a key clinical need for rapid diagnosis in the acute phase of the disease.
• Emphasis on HEV Genotype Differentiation: Of increasing interest is the creation of rapid test kits that can distinguish between the main HEV genotypes, especially genotypes 1 and 3, which are common in various parts of the world. The effect is finer-grained information regarding HEV epidemiology as well as more targeted clinical management. This innovation is important for research and surveillance and can guide targeted public health interventions to contain the transmission of particular HEV variants.
• Recombinant Antigen Use: There is a growing trend among manufacturers to employ recombinant antigens in their rapid test kits to enhance performance. The genetically engineered antigens provide greater purity and consistency than their native virus counterparts. The result is enhanced sensitivity and specificity of the kits, resulting in more dependable results as well as less confirmatory testing. This advantage contributes to increased confidence in the rapid diagnostic platform.
• Enlargement of Serological and Molecular Diagnostic Panels: An important advance is the enlargement of diagnostic panels to cover both serological (antibody) and molecular (RNA) HEV tests. This gives a complete approach to diagnosis, enabling clinicians to identify both acute and chronic infection and assess viral load. The effect is an enhanced diagnostic picture that is vital in dealing with a complicated infection like HEV, especially in immunocompromised hosts.

All of these five major advancements are profoundly influencing the hepatitis E virus rapid test kit market. Emphasis on high-performance automation, advanced antigen detection, and enhanced specificity is rendering the tests more efficient and versatile. These advancements are not only enhancing product characteristics but also assisting in enhancing the level of patient care and public health surveillance so that HEV can be diagnosed and treated more effectively.

Strategic Growth Opportunities in the Hepatitis E Virus Rapid Test Kit Market

The hepatitis E virus rapid test kit market offers many strategic growth opportunities across major applications, fueled by the intersection of technological innovation, demographic change, and changing public health needs. Although the market appears niche in nature, innovation and specialization are bringing new areas of expansion. These opportunities emphasize the use of the inherent strengths of rapid tests, for instance, speed and simplicity, to improve their performance and utility in a broader array of clinical and public health environments.

• Public Health Surveillance and Outbreak Control: This market is a core and established growth opportunity. The large frequency of HEV outbreaks in developing countries and the urgency to react quickly with a public health response establish a permanent and high-volume market. Firms can specialize in producing and commercializing rapid test kits for public health applications, which can capture a large and stable market share and form close collaborations with government and non-governmental agencies engaged in disease control activities.
• Screening of Blood and Organ Donors: Screening blood and organ donors for HEV is a significant growth opportunity. There is increasing consciousness of the risk of HEV transmission via blood transfusion and organ transplantation, and this has resulted in more stringent screening regulations. By developing and selling very sensitive HEV rapid tests to blood banks and transplant facilities, businesses are able to sell into a high-value niche segment of the market and help make a dramatic increase in patient safety.
• Veterinary Medicine: The veterinary industry is an important growth prospect. HEV is a recognized zoonotic infection, and swine is an important reservoir. There is growing demand for HEV surveillance in animals, especially in pig farms, to avoid both animal and human infections. Businesses can ride on this trend by creating HEV rapid test kits for veterinary applications. This market focus can ensure deeper market penetration and create a new, expanding application field.
• Immunocompromised Patient Diagnostics: Immunocompromised patient diagnostics, including those with HIV or transplant recipients, represent a prime area for HEV diagnostic growth. In these patients, HEV has the potential to cause chronic infection and liver disease, and thus early detection is essential. Firms may target the development of highly sensitive rapid test kits specifically validated for use in these patients to meet a high-value and critical clinical need.
• Travel Health and Screening: With the resumption of international travel, there is also an increased emphasis on screening passengers for infectious diseases, especially returnees from endemic areas. This is a stable and sustainable growth potential. By packaging HEV rapid test kits as part of a travel health clinic or a screening program, businesses can address an important need and diversify their product line into a new and critical segment of the market.

These opportunities for strategic growth are influencing the hepatitis E virus rapid test kit market by moving away from a one-size-fits-all solution to focused, application-specific solutions. Through product specialization in high-growth applications such as blood screening and veterinary medicine, and through leveraging the fast growth of public health surveillance programs, firms can maintain the profitability and relevance of HEV rapid tests despite a competitive and changing medical environment.

Hepatitis E Virus Rapid Test Kit Market Driver and Challenges

The hepatitis E virus rapid test kit market is influenced by a dynamic relationship of key drivers that fuel its expansion and key challenges that can limit its growth. The drivers, namely the high incidence of HEV and increasing emphasis on public health, are driving the market, whereas challenges of no standard diagnostic method and existing low-cost substitutes need to be addressed through careful strategy management. Comprehending this equilibrium is important for firms in this market to develop winning strategies for success.

The factors responsible for driving the hepatitis E virus rapid test kit market include:

1. High Incidence of Hepatitis E: One of the main drivers is the high worldwide incidence of HEV, especially among developing nations in Asia and Africa. HEV is a major cause of acute viral hepatitis, and its route of transmission via polluted water and food sources provides a constant and large patient base for diagnosis. This large disease burden is an underlying force that guarantees a consistent demand for quick test kits, and as such, it is a stable market with high growth prospects.

2. Growing Awareness and Public Health Programs: The increasing awareness of HEV among the general public and healthcare providers is a key market force. Public health programs and government policies aimed at containing viral hepatitis outbreaks are driving demand for screening and surveillance products. This emphasis on public health is driving the demand for rapid test kits to become widespread across endemic areas in order to enable early diagnosis and outbreak control.

3. Movement Towards Point-of-Care Diagnosis: The worldwide movement towards point-of-care (POC) testing is the principal driving force behind the HEV rapid test kit market. POC tests provide quick diagnosis without the requirement of advanced laboratory facilities, which is an imperative for the control of HEV in rural or resource-constrained environments. This transition is increasing HEV diagnosis accessibility and efficiency, which, in turn, drives the market growth through increased potential demand from more users.

4. Increasing Prevalence of Zoonotic Transmission: With growing awareness of HEV as a zoonotic infection, especially in the developed world where eating contaminated pork and other animal products is the leading cause of infection, there has emerged a new market demand for HEV diagnostics. The necessity to test human patients as well as animal populations is a prime driver that is furthering the market into new applications such as veterinary diagnostics and food safety.

5. Significance of Blood and Organ Screening: The heightened concern regarding the risk of HEV transmission by blood transfusions and organ transplant is a major impeller. This has initiated the drive for routine HEV screening of blood banks and transplant facilities. Bodies governing policy in certain geographies have advocated or mandated this screening, which represents a predictable and large-volume demand for highly sensitive rapid test kits, thus driving the market.

Challenges in the hepatitis E virus rapid test kit market are:

1. Absence of Standardized Diagnostic Method: One of the big challenges is the absence of a globally standardized diagnostic method for HEV. Different countries and clinical guidelines might suggest various testing methods, like serological tests versus molecular tests. This may result in confusion and variability in diagnosis and prove to be an impediment to market expansion. The absence of a standard makes it challenging for organizations to create one product that will serve all clinical purposes.

2. Substandard and Low-Cost Products: The market, especially in the developing world, is put under pressure by several low-cost, and at times substandard, rapid test kits. Such products can lack the necessary sensitivity or specificity, and therefore provide misleading results, and a lack of confidence among clinicians. This competition from untested products puts pressure on pricing and can also stifle the growth of firms that spend resources on research and development of high-quality products.

3. Lack of Awareness Outside Non-Endemic Areas: Although HEV is a problem in developed nations, public knowledge of the virus is generally poor. In most non-endemic areas, HEV is not included within normal screening panels, resulting in under-diagnosis and a restricted market. Poor awareness and a perceived low risk can be an important impediment to market growth and can hinder manufacturers from entering new markets.

The hepatitis E virus rapid test kit market is driven by strong drivers, namely a high disease burden and increasing emphasis on public health. Yet, the market is subjected to major challenges, mainly because of the absence of a standardized diagnostic strategy and the availability of low-quality, low-priced products. Its future will rely on whether it can utilize its benefits of saving lives by establishing a standard of quality and performance, thus surmounting the disadvantages of a splinter market and lack of universal knowledge.

List of Hepatitis E Virus Rapid Test Kit Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hepatitis E virus rapid test kit companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hepatitis E virus rapid test kit companies profiled in this report include-

• CTK Biotech
• Abbexa
• Fortress Diagnostics
• MP Diagnostics
• Healgen
• Bio-Medical Laboratory Supplies
• Creative Diagnostics
• Athenese-Dx
• Biozek Medical
• Diagnostic Automation / Cortez Diagnostics

Hepatitis E Virus Rapid Test Kit Market by Segment

The study includes a forecast for the global hepatitis E virus rapid test kit market by type, application, and region.

Hepatitis E Virus Rapid Test Kit Market by Type [Value from 2019 to 2031]:

• Enzyme-Linked Immunoassay
• Probe Method
• Colloidal Gold Method
• Others

Hepatitis E Virus Rapid Test Kit Market by Application [Value from 2019 to 2031]:

• Diagnostic Center
• Hospital
• Family Expenses

Country Wise Outlook for the Hepatitis E Virus Rapid Test Kit Market

The hepatitis E virus rapid test kit market is witnessing an immense boost due to an increased international consciousness of the virus and the requirement for immediate, precise diagnosis. HEV is a significant etiological agent for acute viral hepatitis in developing countries. Current advancements are aimed at enhancing the speed, sensitivity, and availability of the test, progressing from conventional laboratory-based tests to point-of-care testing. This development is crucial for early detection, outbreak control, and blood safety, especially in endemic regions and for high-risk groups.

• United States: In the United States, the HEV rapid test kit market represents a small but expanding niche market, led primarily by demand to test for non-endemic travel-, zoonotic-, or imported infections. Emerging trends are geared towards high-quality, automated immunoassay platforms that are capable of being inserted into large-scale laboratory testing processes. There is more focus on creating tests that differentiate between acute and remote infections by detecting both IgG and IgM antibodies. There is also a growing presence of specialized kits for immunocompromised patients and blood screening.
• China: Chinas market is a significant force behind global growth because HEV prevalence is high and there is a huge population. Developments that have occurred recently are dominated by the substantial growth of local production of rapid diagnostic kits. They tend to be cheaper, which is vital for mass use. The government has placed emphasis on public health programs in order to stem infectious diseases, and this has resulted in a strong demand for low-cost and effective HEV rapid tests, especially for clinical diagnosis and epidemiological surveillance.
• Germany: Germany possesses a quality-oriented and mature market, together with a high focus on clinical research as well as compliance with European Union standards. Recent progress focuses on the development of more sensitive and specific serological as well as molecular assays. German manufacturers are pioneers in designing kits capable of identifying various HEV genotypes. The market is driven by a need to offer reliable diagnostic products for clinicians to treat severe cases and screen risk groups, including transplant recipients and travelers to endemic regions.
• India: The Indian market is a high-growth market, fueled by the high incidence of HEV outbreaks due to contaminated water sources. The latest trends are dominated by the demand for low-cost, user-friendly, and highly sensitive rapid test kits. The market is facing competition from a number of local firms introducing competitively priced products at the expense of imports. There is emphasis on increasing the geographical reach of diagnostic services to rural and rural remote areas to support a faster response in HEV outbreaks and enhance overall public health surveillance.
• Japan: Japan boasts a technologically developed market where there is much emphasis on high-quality and innovative diagnostic equipment. Recent efforts are focused on developing HEV rapid test kits with high sensitivity as well as specificity. Japanese scientists as well as companies are leading the way in the development of assays that can identify the virus using non-conventional specimens, e.g., stool and urine, for further epidemiological research. The market is also driven by interest in screening for HEV in blood donors and organ transplant candidates in order to avoid iatrogenic transmission.

Features of the Global Hepatitis E Virus Rapid Test Kit Market

• Market Size Estimates: Hepatitis E virus rapid test kit market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Hepatitis E virus rapid test kit market size by type, application, and region in terms of value ($B).
• Regional Analysis: Hepatitis E virus rapid test kit market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the hepatitis E virus rapid test kit market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hepatitis E virus rapid test kit market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the hepatitis E virus rapid test kit market by type (enzyme-linked immunoassay, probe method, colloidal gold method, and others), application (diagnostic center, hospital, and family expenses), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Hepatitis E Virus Rapid Test Kit Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Enzyme-Linked Immunoassay: Trends and Forecast (2019-2031)
• 4.4 Probe Method: Trends and Forecast (2019-2031)
• 4.5 Colloidal Gold Method: Trends and Forecast (2019-2031)
• 4.6 Others: Trends and Forecast (2019-2031)

5. Global Hepatitis E Virus Rapid Test Kit Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Diagnostic Center: Trends and Forecast (2019-2031)
• 5.4 Hospital: Trends and Forecast (2019-2031)
• 5.5 Family Expenses: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Hepatitis E Virus Rapid Test Kit Market by Region

7. North American Hepatitis E Virus Rapid Test Kit Market

• 7.1 Overview
• 7.2 North American Hepatitis E Virus Rapid Test Kit Market by Type
• 7.3 North American Hepatitis E Virus Rapid Test Kit Market by Application
• 7.4 United States Hepatitis E Virus Rapid Test Kit Market
• 7.5 Mexican Hepatitis E Virus Rapid Test Kit Market
• 7.6 Canadian Hepatitis E Virus Rapid Test Kit Market

8. European Hepatitis E Virus Rapid Test Kit Market

• 8.1 Overview
• 8.2 European Hepatitis E Virus Rapid Test Kit Market by Type
• 8.3 European Hepatitis E Virus Rapid Test Kit Market by Application
• 8.4 German Hepatitis E Virus Rapid Test Kit Market
• 8.5 French Hepatitis E Virus Rapid Test Kit Market
• 8.6 Spanish Hepatitis E Virus Rapid Test Kit Market
• 8.7 Italian Hepatitis E Virus Rapid Test Kit Market
• 8.8 United Kingdom Hepatitis E Virus Rapid Test Kit Market

9. APAC Hepatitis E Virus Rapid Test Kit Market

• 9.1 Overview
• 9.2 APAC Hepatitis E Virus Rapid Test Kit Market by Type
• 9.3 APAC Hepatitis E Virus Rapid Test Kit Market by Application
• 9.4 Japanese Hepatitis E Virus Rapid Test Kit Market
• 9.5 Indian Hepatitis E Virus Rapid Test Kit Market
• 9.6 Chinese Hepatitis E Virus Rapid Test Kit Market
• 9.7 South Korean Hepatitis E Virus Rapid Test Kit Market
• 9.8 Indonesian Hepatitis E Virus Rapid Test Kit Market

10. ROW Hepatitis E Virus Rapid Test Kit Market

• 10.1 Overview
• 10.2 ROW Hepatitis E Virus Rapid Test Kit Market by Type
• 10.3 ROW Hepatitis E Virus Rapid Test Kit Market by Application
• 10.4 Middle Eastern Hepatitis E Virus Rapid Test Kit Market
• 10.5 South American Hepatitis E Virus Rapid Test Kit Market
• 10.6 African Hepatitis E Virus Rapid Test Kit Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Hepatitis E Virus Rapid Test Kit Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 CTK Biotech
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Abbexa
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Fortress Diagnostics
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 MP Diagnostics
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Healgen
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Bio-Medical Laboratory Supplies
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Creative Diagnostics
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Athenese-Dx
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Biozek Medical
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Diagnostic Automation / Cortez Diagnostics
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us

List of Figures

• Figure 1.1: Trends and Forecast for the Global Hepatitis E Virus Rapid Test Kit Market
• Figure 2.1: Usage of Hepatitis E Virus Rapid Test Kit Market
• Figure 2.2: Classification of the Global Hepatitis E Virus Rapid Test Kit Market
• Figure 2.3: Supply Chain of the Global Hepatitis E Virus Rapid Test Kit Market
• Figure 3.1: Driver and Challenges of the Hepatitis E Virus Rapid Test Kit Market
• Figure 3.2: PESTLE Analysis
• Figure 3.3: Patent Analysis
• Figure 3.4: Regulatory Environment
• Figure 4.1: Global Hepatitis E Virus Rapid Test Kit Market by Type in 2019, 2024, and 2031
• Figure 4.2: Trends of the Global Hepatitis E Virus Rapid Test Kit Market ($B) by Type
• Figure 4.3: Forecast for the Global Hepatitis E Virus Rapid Test Kit Market ($B) by Type
• Figure 4.4: Trends and Forecast for Enzyme-Linked Immunoassay in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Figure 4.5: Trends and Forecast for Probe Method in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Figure 4.6: Trends and Forecast for Colloidal Gold Method in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Figure 4.7: Trends and Forecast for Others in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Figure 5.1: Global Hepatitis E Virus Rapid Test Kit Market by Application in 2019, 2024, and 2031
• Figure 5.2: Trends of the Global Hepatitis E Virus Rapid Test Kit Market ($B) by Application
• Figure 5.3: Forecast for the Global Hepatitis E Virus Rapid Test Kit Market ($B) by Application
• Figure 5.4: Trends and Forecast for Diagnostic Center in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Figure 5.5: Trends and Forecast for Hospital in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Figure 5.6: Trends and Forecast for Family Expenses in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Figure 6.1: Trends of the Global Hepatitis E Virus Rapid Test Kit Market ($B) by Region (2019-2024)
• Figure 6.2: Forecast for the Global Hepatitis E Virus Rapid Test Kit Market ($B) by Region (2025-2031)
• Figure 7.1: North American Hepatitis E Virus Rapid Test Kit Market by Type in 2019, 2024, and 2031
• Figure 7.2: Trends of the North American Hepatitis E Virus Rapid Test Kit Market ($B) by Type (2019-2024)
• Figure 7.3: Forecast for the North American Hepatitis E Virus Rapid Test Kit Market ($B) by Type (2025-2031)
• Figure 7.4: North American Hepatitis E Virus Rapid Test Kit Market by Application in 2019, 2024, and 2031
• Figure 7.5: Trends of the North American Hepatitis E Virus Rapid Test Kit Market ($B) by Application (2019-2024)
• Figure 7.6: Forecast for the North American Hepatitis E Virus Rapid Test Kit Market ($B) by Application (2025-2031)
• Figure 7.7: Trends and Forecast for the United States Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 7.8: Trends and Forecast for the Mexican Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 7.9: Trends and Forecast for the Canadian Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 8.1: European Hepatitis E Virus Rapid Test Kit Market by Type in 2019, 2024, and 2031
• Figure 8.2: Trends of the European Hepatitis E Virus Rapid Test Kit Market ($B) by Type (2019-2024)
• Figure 8.3: Forecast for the European Hepatitis E Virus Rapid Test Kit Market ($B) by Type (2025-2031)
• Figure 8.4: European Hepatitis E Virus Rapid Test Kit Market by Application in 2019, 2024, and 2031
• Figure 8.5: Trends of the European Hepatitis E Virus Rapid Test Kit Market ($B) by Application (2019-2024)
• Figure 8.6: Forecast for the European Hepatitis E Virus Rapid Test Kit Market ($B) by Application (2025-2031)
• Figure 8.7: Trends and Forecast for the German Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 8.8: Trends and Forecast for the French Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 8.9: Trends and Forecast for the Spanish Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 8.10: Trends and Forecast for the Italian Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 8.11: Trends and Forecast for the United Kingdom Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 9.1: APAC Hepatitis E Virus Rapid Test Kit Market by Type in 2019, 2024, and 2031
• Figure 9.2: Trends of the APAC Hepatitis E Virus Rapid Test Kit Market ($B) by Type (2019-2024)
• Figure 9.3: Forecast for the APAC Hepatitis E Virus Rapid Test Kit Market ($B) by Type (2025-2031)
• Figure 9.4: APAC Hepatitis E Virus Rapid Test Kit Market by Application in 2019, 2024, and 2031
• Figure 9.5: Trends of the APAC Hepatitis E Virus Rapid Test Kit Market ($B) by Application (2019-2024)
• Figure 9.6: Forecast for the APAC Hepatitis E Virus Rapid Test Kit Market ($B) by Application (2025-2031)
• Figure 9.7: Trends and Forecast for the Japanese Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 9.8: Trends and Forecast for the Indian Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 9.9: Trends and Forecast for the Chinese Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 9.10: Trends and Forecast for the South Korean Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 9.11: Trends and Forecast for the Indonesian Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 10.1: ROW Hepatitis E Virus Rapid Test Kit Market by Type in 2019, 2024, and 2031
• Figure 10.2: Trends of the ROW Hepatitis E Virus Rapid Test Kit Market ($B) by Type (2019-2024)
• Figure 10.3: Forecast for the ROW Hepatitis E Virus Rapid Test Kit Market ($B) by Type (2025-2031)
• Figure 10.4: ROW Hepatitis E Virus Rapid Test Kit Market by Application in 2019, 2024, and 2031
• Figure 10.5: Trends of the ROW Hepatitis E Virus Rapid Test Kit Market ($B) by Application (2019-2024)
• Figure 10.6: Forecast for the ROW Hepatitis E Virus Rapid Test Kit Market ($B) by Application (2025-2031)
• Figure 10.7: Trends and Forecast for the Middle Eastern Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 10.8: Trends and Forecast for the South American Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 10.9: Trends and Forecast for the African Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 11.1: Porter's Five Forces Analysis of the Global Hepatitis E Virus Rapid Test Kit Market
• Figure 11.2: Market Share (%) of Top Players in the Global Hepatitis E Virus Rapid Test Kit Market (2024)
• Figure 12.1: Growth Opportunities for the Global Hepatitis E Virus Rapid Test Kit Market by Type
• Figure 12.2: Growth Opportunities for the Global Hepatitis E Virus Rapid Test Kit Market by Application
• Figure 12.3: Growth Opportunities for the Global Hepatitis E Virus Rapid Test Kit Market by Region
• Figure 12.4: Emerging Trends in the Global Hepatitis E Virus Rapid Test Kit Market

List of Tables

• Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Hepatitis E Virus Rapid Test Kit Market by Type and Application
• Table 1.2: Attractiveness Analysis for the Hepatitis E Virus Rapid Test Kit Market by Region
• Table 1.3: Global Hepatitis E Virus Rapid Test Kit Market Parameters and Attributes
• Table 3.1: Trends of the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 3.2: Forecast for the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 4.1: Attractiveness Analysis for the Global Hepatitis E Virus Rapid Test Kit Market by Type
• Table 4.2: Market Size and CAGR of Various Type in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 4.3: Market Size and CAGR of Various Type in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 4.4: Trends of Enzyme-Linked Immunoassay in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 4.5: Forecast for Enzyme-Linked Immunoassay in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 4.6: Trends of Probe Method in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 4.7: Forecast for Probe Method in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 4.8: Trends of Colloidal Gold Method in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 4.9: Forecast for Colloidal Gold Method in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 4.10: Trends of Others in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 4.11: Forecast for Others in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 5.1: Attractiveness Analysis for the Global Hepatitis E Virus Rapid Test Kit Market by Application
• Table 5.2: Market Size and CAGR of Various Application in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 5.3: Market Size and CAGR of Various Application in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 5.4: Trends of Diagnostic Center in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 5.5: Forecast for Diagnostic Center in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 5.6: Trends of Hospital in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 5.7: Forecast for Hospital in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 5.8: Trends of Family Expenses in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 5.9: Forecast for Family Expenses in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 6.1: Market Size and CAGR of Various Regions in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 6.2: Market Size and CAGR of Various Regions in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 7.1: Trends of the North American Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 7.2: Forecast for the North American Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 7.3: Market Size and CAGR of Various Type in the North American Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 7.4: Market Size and CAGR of Various Type in the North American Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 7.5: Market Size and CAGR of Various Application in the North American Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 7.6: Market Size and CAGR of Various Application in the North American Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 7.7: Trends and Forecast for the United States Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 7.8: Trends and Forecast for the Mexican Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 7.9: Trends and Forecast for the Canadian Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 8.1: Trends of the European Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 8.2: Forecast for the European Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 8.3: Market Size and CAGR of Various Type in the European Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 8.4: Market Size and CAGR of Various Type in the European Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 8.5: Market Size and CAGR of Various Application in the European Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 8.6: Market Size and CAGR of Various Application in the European Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 8.7: Trends and Forecast for the German Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 8.8: Trends and Forecast for the French Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 8.9: Trends and Forecast for the Spanish Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 8.10: Trends and Forecast for the Italian Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 8.11: Trends and Forecast for the United Kingdom Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 9.1: Trends of the APAC Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 9.2: Forecast for the APAC Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 9.3: Market Size and CAGR of Various Type in the APAC Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 9.4: Market Size and CAGR of Various Type in the APAC Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 9.5: Market Size and CAGR of Various Application in the APAC Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 9.6: Market Size and CAGR of Various Application in the APAC Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 9.7: Trends and Forecast for the Japanese Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 9.8: Trends and Forecast for the Indian Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 9.9: Trends and Forecast for the Chinese Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 9.10: Trends and Forecast for the South Korean Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 9.11: Trends and Forecast for the Indonesian Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 10.1: Trends of the ROW Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 10.2: Forecast for the ROW Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 10.3: Market Size and CAGR of Various Type in the ROW Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 10.4: Market Size and CAGR of Various Type in the ROW Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 10.5: Market Size and CAGR of Various Application in the ROW Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 10.6: Market Size and CAGR of Various Application in the ROW Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 10.7: Trends and Forecast for the Middle Eastern Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 10.8: Trends and Forecast for the South American Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 10.9: Trends and Forecast for the African Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 11.1: Product Mapping of Hepatitis E Virus Rapid Test Kit Suppliers Based on Segments
• Table 11.2: Operational Integration of Hepatitis E Virus Rapid Test Kit Manufacturers
• Table 11.3: Rankings of Suppliers Based on Hepatitis E Virus Rapid Test Kit Revenue
• Table 12.1: New Product Launches by Major Hepatitis E Virus Rapid Test Kit Producers (2019-2024)
• Table 12.2: Certification Acquired by Major Competitor in the Global Hepatitis E Virus Rapid Test Kit Market